BBA CLINICAL, vol.6, pp.138-142, 2016 (Peer-Reviewed Journal)
Article / Article
Emerging Sources Citation Index, Scopus
Omentin, Diagnostic, Pancreatic adenocancer, Serum, BODY-MASS INDEX, CANCER RISK, CIRCULATING LEVELS, ADIPOKINES, OBESITY
Background: Omentin is related with metabolic syndrome and obesity. Pancreatic adenocarcinoma (PA) is a lethal and obesity-linked malignancy. This study was conducted to investigate the serum levels of omentin in patients with PA and the relationship with tumor progression and known prognostic parameters.